Precise Progerin Targeting Using RfxCas13d: A Therapeutic Avenue for Hutchinson-Gilford Progeria Syndrome
Citations

WEB OF SCIENCE

3
Citations

SCOPUS

4

초록

Hutchinson-Gilford progeria syndrome (HGPS), an extremely rare progressive genetic disorder, is caused by a point mutation in LMNA that induces progerin production, which disrupts cellular function and triggers premature aging and mortality. Despite extensive efforts, HPGS remains incurable. We successfully implemented a strategy using RfxCas13d to selectively target progerin mRNA at specific junction regions, without unintended cleavage and reduce its expression. This technique discriminated between normal lamin A and progerin, thus providing a safe and targeted therapeutic avenue to treat HGPS. Our approach effectively restored aberrant gene expression and progerin-induced cellular phenotypes, including senescence, mitochondrial dysfunction, and DNA damage in cells with HGPS and LMNAG608G/G608G mice. Notably, LMNAG608G/G608G mice exhibited improved progeroid phenotypes, suggesting a potential therapeutic application of this approach for other diseases resulting from abnormal RNA splicing. Copyright © 2025. Published by Elsevier Inc.

키워드

Hutchinson-Gilford progeria syndromelamin Amis-splicingprogerinRfxCas13dDISEASELMNAEXPRESSIONPHENOTYPENUCLEARPATHWAYAGE
제목
Precise Progerin Targeting Using RfxCas13d: A Therapeutic Avenue for Hutchinson-Gilford Progeria Syndrome
저자
Chae, UnbinYang, Hae-JunKim, HanseopLee, Seung HwanLee, Dong GilKoo, Jeong YoungHa, Seung-MinBak, Seo-JongJoo, MinaNam, Hyun HeeLim, Kyung-SeobKang, PhilyongSon, Hee-ChangAn, You JeongKim, Young-HyunSong, In-SungLee, Sang-HeeKim, Hae RimCho, Sang-MiKim, Eun-KyoungNam, Ki-HoanChung, Kyung-SookKim, Jae-YoonKim, Seon-YeopKim, Seon-KyuKim, Seon-YoungLee, Dong-SeokKim, Jin-ManPark, Young-HoKim, Sun-Uk
DOI
10.1016/j.ymthe.2025.06.017
발행일
2025-09
유형
Article
저널명
Molecular Therapy
33
9
페이지
4394 ~ 4413